glp 1 arthritis pain GLP-1 Medications and Rheumatoid Arthritis: What the 2025 Research Actually Shows GLP1 receptor agonist medications may

Research Highlights No peer-reviewed studies published as of June 2025

Nestl launches food line targeting Ozempic, other weight-loss drug users Nestl is launching a line of food products tailored to people using weight-loss medication in an effort to capitalize on a market expected to reach $30 billion in the next six years

Low values identify patients with poor catecholamine responsiveness who may benefit from earlier addition of non-catecholamine vasopressors, such as vasopressin, rather than escalating norepinephrine doses

Reconstructing lost BOLD signal in individual participants using deep machine learning

A simplified graphic demonstrating the differences between endogenous and exogenous GLP-1

Analysis by transcriptomics and metabolomics for the proliferation inhibition and dysfunction through redox imbalance-mediated DNA damage response and ferroptosis in male reproduction of mice and TM4 Sertoli cells exposed to PM(2.5)